Sort   by:  
 Page size 
UnknownAnalysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Not available
S-EPMC4963453 | biostudies-literature
UnknownQuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues.
Not available
S-EPMC4739686 | biostudies-literature
UnknownClinical Nurse Leader Knowledge Production to Quality Improvement in a Seamless Trajectory: A Participatory Research Approach.
Not available
S-EPMC6710131 | biostudies-literature
UnknownPhosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.
Not available
S-EPMC4873402 | biostudies-literature
UnknownIntegrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer.
Not available
S-EPMC12641601 | biostudies-literature
UnknownMicroscaled proteogenomic methods for precision oncology.
Not available
S-EPMC6985126 | biostudies-literature
UnknownProteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers.
Not available
S-EPMC12208316 | biostudies-literature
UnknownTargeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Not available
S-EPMC10721161 | biostudies-literature
UnknownA renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.
Not available
S-EPMC3732575 | biostudies-literature
UnknownTargeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Not available
S-EPMC10557675 | biostudies-literature
Sort   by:  
 Page size